GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Orpea SA (XPAR:ORP) » Definitions » Selling and Marketing Expense

Orpea (XPAR:ORP) Selling and Marketing Expense : €0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Orpea Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Orpea's Selling and Marketing Expense for the six months ended in Dec. 2023 was €0 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2023 was €0 Mil.

Orpea Selling and Marketing Expense Historical Data

The historical data trend for Orpea's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orpea Selling and Marketing Expense Chart

Orpea Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Orpea Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Orpea Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orpea Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Orpea's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Orpea (XPAR:ORP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Orpea SA (XPAR:ORP) » Definitions » Selling and Marketing Expense
Comparable Companies
XPAR:GDS XPAR:CLARI XPAR:LNA HCA SAU:4013 XTER:FRE SZSE:300015 THC BSP:RDOR3 BKK:BDMS XTER:FME DVA UHS XKLS:5225 ADX:PUREHEALTH HKSE:06618 NSE:APOLLOHOSP BOM:543220 EHC CHE
Traded in Other Exchanges
ORPEF:USA ORPp:UK 0NEX:UK OPA:Germany ORP:Austria
Address
12, Rue Jean Jaures, CS 10032, Puteaux Cedex, Paris, FRA, 92 813
Website
https://www.orpea-corp.com
Orpea SA operates a network of long-term, post-acute, psychiatric, and home care facilities in Europe. The majority of the firm's revenue is generated in France. Orpea's long-term care facilities are primarily nursing homes, though it also provides serviced residences for autonomous and semi-autonomous elderly patients. Orpea's post-acute and rehabilitation facilities specialize in geriatrics, musculoskeletal conditions, cardiovascular conditions, nervous system diseases, and, Haematology and oncology. Its psychiatric clinics provide treatment and psychotherapeutic monitoring for a range of conditions.

Orpea (XPAR:ORP) Headlines

No Headlines